TMS Therapy Success Rate
WE CAN HELP! Request a Call Back for a Free Consultation:
Using Health Insurance? Click Here for a Free Insurance Check
Using Health Insurance? Click Here for a Free Insurance Check
The introduction of TMS therapy for treating major depressive disorder (MDD) has been a gift for individuals who were not responsive to traditional antidepressant drug therapy. In fact, according to recent studies on the effectiveness of antidepressants, only about half of the patients trialing antidepressants to treat major depression found the drugs to be effective. These individuals had few options until the FDA cleared TMS therapy for treating MDD in 2008.
The clearance of TMS for treating major depression did not occur in a vacuum. Prior to being cleared several clinical studies were conducted, demonstrating that TMS therapy is a safe and effective treatment option for individuals with treatment-resistant MDD. Since the early 2000s, countless clinical trials have continued to point to the high response and remission rates of TMS therapy.
Clinical trials have continued to show promising results for individuals struggling with major depression and depression with co-occurring anxiety. Statistically significant success rates are measured using assessment instruments such as the Hamilton Depression Rating Scale, the Hamilton Anxiety Rating Scale, the Clinical Global Impression scale, and other psychological assessment tools. Following are a small sampling of trial summaries that demonstrate the safety and efficacy of TMS therapy for treating the symptoms of depression and anxiety.
TMS trials continue to be conducted globally in order to further assess the value of TMS therapy in treating mental health disorders. As new potential applications are considered, in both medicine and psychiatry, clinical studies of TMS will continue to broaden.